INCY

Incyte Corporation · Healthcare · Biotechnology
$124.37
-3.37 (-2.64%)
Mkt Cap: 25.21B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield7.0%
Dividend YieldN/A
Market Cap25.21B
Volume1.22M
Recent News
84,502 Shares in Incyte Corporation $INCY Bought by Beacon Pointe Advisors LLC
defenseworld.net · 2026-08-29
Knight Therapeutics Announces Supplemental Regulatory Submission for MINJUVI® (tafasitamab) in Brazil
globenewswire.com · 2026-08-27
Incyte (INCY) Up 0.8% Since Last Earnings Report: Can It Continue?
zacks.com · 2026-08-27
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Analog Devices, Crown Castle, ebay, EPR Properties, Etsy, Merck & Co., Shopify, TJX Companies, and More
247wallst.com · 2026-08-20
Global Vitiligo Foundation Applauds Incyte's “Moments of Clarity” Campaign for Elevating Patient Voices and Advancing Vitiligo Awareness
businesswire.com · 2026-08-17
Incyte Sales Growth Drives Share Price Gains
fxempire.com · 2026-08-12

Unlock the Full Deep Scan

9 AI agents analyze INCY across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →